Showing results (601-610 of 653) with videos related to

Sort By:
Pageof 66
Cancers|December 30, 2020
Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic CancerNana Kimura, Suguru Yamada, Hideki Takami, et al.
Oncotargets and Therapy|December 24, 2013
A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patientsMasaya Suenaga, Suguru Yamada, Tsutomu Fujii, et al.
Pancreas|October 5, 2018
Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image ClassificationDaishi Morimoto, Suguru Yamada, Kenta Murotani, et al.
Molecular Cancer|February 12, 2022
A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter studyJinsei Miyoshi, Zhongxu Zhu, Aiping Luo, et al.
Annals of Gastroenterological Surgery|March 9, 2022
International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1)Kazuhiro Yoshida, Itaru Yasufuku, Masanori Terashima, et al.
Annals of Surgical Oncology|July 2, 2016
Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric CancerMitsuro Kanda, Dai Shimizu, Tsutomu Fujii, et al.
Epigenetics|November 4, 2017
PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinomaKeisuke Kurimoto, Masamichi Hayashi, Rafael Guerrero-Preston, et al.
International Journal of Clinical Oncology|January 2, 2021
Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysisPipit Burasakarn, Ryota Higuchi, Souya Nunobe, et al.
Annals of Surgical Oncology|October 31, 2013
Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10Kazuo Yamamura, Hideki Kasuya, Tevfik Tolga Sahin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2019
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled TrialKazuhiro Yoshida, Yasuhiro Kodera, Mitsugu Kochi, et al.
Pageof 66